All sites C00-96,D32-33,D42-43,D45-47,D76 462 92.5 0.8 4.0 0.9 1.8
Mouth, pharynx C00-14 12 96.6 1.7 - 1.7 -
  Lip C00 2 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 33.3 33.3 - 33.3 -
  Pharynx C01,C09-14 3 100.0 - - - -
Digestive organs C15-26 93 87.8 1.1 7.9 1.9 1.3
  Oesophagus C15 9 95.7 - 2.2 2.2 -
  Stomach C16 8 100.0 - - - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 27 96.2 - 1.5 0.8 1.5
  Rectum, rectosigmoid C19-20 17 95.4 - 3.4 1.1 -
  Anus C21 0 100.0 - - - -
  Liver C22 7 94.3 - 2.9 2.9 -
  Gallbladder, bile ducts C23-24 3 76.9 - 15.4 7.7 -
  Pancreas C25 21 63.1 4.9 25.2 2.9 3.9
  Other digestive organs C26 1 - - 66.7 33.3 -
Respiratory organs C30-39 53 80.4 1.1 13.6 1.5 3.4
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 48 78.8 1.2 14.5 1.7 3.7
  Mediastinum, pleura C38 1 66.7 - 33.3 - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 16 100.0 - - - -
Skin, non-melanoma C44 33 99.4 0.6 - - -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 140 99.0 - 0.3 0.1 0.6
  Prostate C61 135 99.0 - 0.3 0.1 0.6
  Testis C62 3 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 44 96.3 - 0.9 0.5 2.3
  Kidney C64 17 90.5 - 2.4 1.2 6.0
  Bladder and urinary tract2 C65-68 27 100.0 - - - -
Eye C69 1 66.7 - 33.3 - -
Brain, central nervous system C70-72,D32-33,D42-43 11 92.7 - 3.6 1.8 1.8
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 11 62.3 - 24.5 5.7 7.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 42 90.0 3.8 - - 6.2
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 20 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 92.0 - - - 8.0
  Leukaemia C91-95 6 74.2 16.1 - - 9.7
  Myelodysplastic syndromes D46 2 25.0 12.5 - - 62.5
  Myeloproliferaitive neoplasms D45,D47 6 84.4 6.3 - - 9.4
Not included above
  Basal cell carcinoma of the skin 79 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.